Brief: Mayne Pharma Group Says FIRB Extends Deadline For Decision To 20 November 2025
18/11/2025 24:54
Nov 18 (Reuters) - Mayne Pharma Group Ltd MYX.AX: UPDATE ON FIRB APPROVAL AND SCHEME FIRB EXTENDS DEADLINE FOR DECISION TO 20 NOVEMBER 2025 Further company coverage: MYX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mayne Pharma
See all newsBrief: Mayne Pharma Group Says It Settles Us Patent Litigation Re Imvexxy With Teva USA
Deals of the day-Mergers and acquisitions
Brief: Mayne Pharma Says Supreme Court Dismisses Cosette Appeal
Deals of the day-Mergers and acquisitions
Australian court dismisses Cosette appeal to drop Mayne Pharma takeover (updated)